Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 The Rise in Prevalence of Obesity Cases
4.2.2 Increased Reluctance Toward Surgical Procedures
4.3 Market Restraints
4.3.1 Lack of Awareness about Cellulite Treatment in Emerging Countries
4.3.2 Adoption of Substituent Traditional and Herbal Massage Therapies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Procedure
5.1.1 Minimally Invasive
5.1.2 Non-invasive
5.1.3 Topical
5.2 By Cellulite
5.2.1 Soft Cellulite
5.2.2 Hard Cellulite
5.2.3 Edematous Cellulite
5.3 By End User
5.3.1 Hospitals
5.3.2 Cosmetic Surgery Centers
5.3.3 Specialized Dermatology Clinics
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Merz Pharma GmbH & Co KGaA
6.1.2 Inceler Medikal Co. Ltd
6.1.3 Candela Corporation
6.1.4 Hologic Inc.
6.1.5 Cutera Inc.
6.1.6 Nestle SA
6.1.7 Tanceuticals LLC
6.1.8 Zimmer Aesthetics
6.1.9 cymedics GmbH & Co KG
6.1.10 Beijing Nubway S&T Co Ltd


7 MARKET OPPORTUNITIES AND FUTURE TRENDS